Tag
Moderna announced FDA approval of mFLUSIVA (mRNA-1010), a seasonal influenza vaccine for adults 50 and older, following unanimous advisory committee recommendations.
A Japanese company called Iris has developed Nodoca, an AI-powered device that analyzes throat images to diagnose influenza in seconds, eliminating uncomfortable nasal swabs. Already approved in Japan and used at over 2,000 institutions, it is expanding to detect other conditions like Covid-19 and potentially lifestyle diseases.
A global review led by UBC researchers confirms that mRNA vaccines are safe and highly effective against COVID-19, and have potential applications for influenza, RSV, cancer, and autoimmune disorders, addressing misconceptions and supporting evidence-based decisions.